Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress-Reference-Cited by-同舟云学术

Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress

Published:2022-03 Issue: Volume:816 Page:146171
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Jabbarzadeh Kaboli Parham,Luo Shuang,Chen Yao,Jomhori Masume,Imani Saber,Xiang Shixin,Wu Zhigui,Li Mingxing,Shen Jing,Zhao Yueshui,Wu Xu,Hin Cho Chi,Xiao Zhangang

Funder

Southwest Medical University

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference52 articles.

1. Multifaceted role of the placental growth factor (PlGF) in the antitumor immune response and cancer progression;Albonici;Int. J. Mol. Sci.,2019

2. Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma;Aoki;Gut,2022

3. Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy;Barrios;Can. Microenviron. Off. J. Int. Cancer Microenviron. Soc.,2009

4. Translating the role of PARP inhibitors in triple-negative breast cancer;Beniey;Oncoscience,2019

5. CDK4-CDK6 inhibitors induce autophagy-mediated degradation of DNMT1 and facilitate the senescence antitumor response;Bourdeau;Autophagy,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research trends on nanomaterials in triple negative breast cancer (TNBC): a bibliometric analysis from 2010 to 2024;Drug Delivery and Translational Research;2024-09-06

2. Recent Advances in Immunotherapy and Targeted Therapy of Triple Negative Breast Cancer;Current Pharmaceutical Biotechnology;2024-07-31

3. Integrating Chinese medicine into mainstream cancer therapies: a promising future;Frontiers in Oncology;2024-06-18

4. YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway;Biology Direct;2024-06-03

5. Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer;Cancer Letters;2024-04